Flanders Institute for Biotechnology / Vlaams Instituut voor Biotechnologie (VIB)

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, et al. Journal article Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann M, et al. Journal article Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium (2017) Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching P, Beckmann M, et al. Journal article Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, et al. Journal article Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (2017) Glubb DM, Johnatty SE, Quinn MCJ, O'Mara TA, Tyrer JP, Gao B, Fasching P, et al. Journal article TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) Fagerholm R, Khan S, Schmidt MK, Garcia-Closas M, Heikkila P, Saarela J, Beesley J, et al. Journal article Erratum: Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs (Nature Microbiology (2016) 2 (16189)) (2016) Javaheri A, Kruse T, Moonens K, Mejias-Luque R, Debraekeleer A, Asche I, Tegtmeyer-Backert N, et al. Journal article, Erratum Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs (2016) Javaheri A, Kruse T, Moonens K, Mejias-Luque R, Debraekeleer A, Asche CI, Tegtmeyer-Backert N, et al. Journal article rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk (2016) Liu J, Loncar I, Collee JM, Bolla MK, Dennis J, Michailidou K, Wang Q, et al. Journal article An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression (2016) Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, et al. Journal article